Innovative aptasensor technology integrates with smartwatches to monitor estrogen and progesterone in sweat, providing insights into reproductive health and personalized care.
This innovative solution leverages the integration of fluorescent aptamer-based biosensors, known as aptasensors, with smartwatches to continuously monitor hormonal levels, specifically estrogen and progesterone, in sweat. By utilizing existing smartwatch technology, this approach enables real-time tracking of hormone fluctuations, offering potential applications in personalized health care, fertility tracking, and timely health interventions. The use of aptamers, which are DNA-based ligands, ensures high specificity and binding affinity to the target hormones, allowing for accurate detection.
Key features include:
This technology is currently at TRL 3, indicating that it has been demonstrated in experimental settings. Future validation plans include testing biosensor sensitivity with artificial sweat, calibration using a fluorescence response curve, and volunteer trials to monitor hormone fluctuations over menstrual cycles. These steps will further validate the technology and prepare it for potential commercial deployment.
University of Waterloo is a public research university in Ontario, Canada, known for an entrepreneurial, STEM‑driven culture. A globally recognized co‑op program places students with employers year‑round, creating direct talent pipelines and de‑risked pathways into sponsored research and contract development. An adjacent research and technology park hosts corporate R&D alongside faculty labs, and the campus sits within the Toronto–Waterloo innovation corridor for ready access to partners, investors, and scale‑up resources. Research is supported by competitive federal funding from Canada’s Tri‑Council agencies (NSERC, CIHR, SSHRC) and international programs. A creator‑owned IP policy and a dedicated tech transfer office enable flexible agreements, licensing, and spinouts.